Associate Director, Trade Operations

The Role

The Associate Director of Trade Operations will oversee the physical and financial flow of Cogent Biosciences' portfolio, starting with the launch of bezuclastinib. Responsibilities include managing 3PL and specialty distributor operations, ensuring seamless distribution, supporting account management, and collaborating with cross-functional teams.

Responsibilities

• Trade Operations - Oversee 3PL and specialty distributor operations including new customer onboarding, pricing updates, inventory management, order to cash process, support chargeback management, returns and any distribution related discrepancies within customers.
• Supply Chain Integrity - Ensure seamless distribution of high value products and manage inventory to ensure patient access.
• Data & Analytics - Monitor 852/867 as well as other data feeds to track product movement, channel pull through and produce ad hoc reporting.
• Support account management - Support QBR preparation and development of long term partnerships.
• Cross Functional Collaboration - Partner with colleagues from Market Access, Supply Chain, Commercial Ops, Quality, Patient Services and Marketing to ensure distribution model supports the overall patient journey and brand strategy.

Qualifications

• Minimum Education & Experience Requirements: Bachelor’s degree required. Master’s degree, MBA a plus; 8+ years of pharmaceutical trade & distribution experience with a heavy preference for rare disease or oncology experience within 3PL and specialty distributors.
• Knowledge / Skills Needed: Understanding of the current healthcare landscape, compliant manufacturer practices, 3Rd Party Logistics, product distribution, and product fulfillment; Strong analytical skills with a proven ability to determine trends and inform strategy; Ability to build strong customer relationships, strategic planning and influencing skills; Knowledge of data flow, chargeback management and or DSCSA requirements; Excellent verbal and written communication skills; Proficient in Microsoft Excel, Word, and PowerPoint; Demonstrated leadership and management skills.
• Personal Attributes Needed: Ability to engage with customers and resolve product fulfillment issues or challenges; Demonstrated ability to develop effective / collaborative working relationships with Field teams, Brand teams and home office functions; Ability to understand business requirements, market dynamics and propose solutions, gain alignment and execute; Proven ability to identify issues and provide effective solutions to address them. Ability to effectively communicate the solution and its value to affected parties; Ability to work with multiple customers simultaneously; Ability to learn and work autonomously.

Pay

$200k - $230k

Location

• Waltham, MA: Open, collaborative office environment with on-site amenities.
• Boulder, CO: Home to Cogent’s discovery research organization and a key scientific hub with strong leadership based on site.

Benefits

• Competitive salary, bonus, and ongoing stock awards.
• Benefits package including 100% medical, dental, and vision premiums, 401(k) match with immediate vesting, generous paid time off, 12 weeks of fully paid parental leave, paid family and medical leave for all employees regardless of location, and company-paid short-term disability coverage for up to 20 weeks.
• Additional perks like wellness programs, tuition reimbursement, and inclusive family-forming support.

About the Company

Cogent Biosciences is a publicly traded biotechnology company focused on developing novel precision therapies to treat a broad range of patients with unmet medical needs. Cogent’s lead program, bezuclastinib, is designed to selectively and potently inhibit exon 17 mutations found within the KIT receptor tyrosine kinase, including KIT D816V. KIT D816V is responsible for driving a rare and serious condition called Systemic Mastocytosis, and exon 17 mutations are also found in patients with gastrointestinal stromal tumors (GIST), a type of cancer with strong dependence on oncogenic KIT signaling. Bezuclastinib has exhibited promising initial data across all three trials: APEX in AdvSM, SUMMIT in NonAdvSM and PEAK in GIST, including an encouraging safety profile across 600+ patients in single agent and combination dosing.